Foresite Capital Management IV as of June 30, 2022
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 8 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 32.8 | $122M | 9.7M | 12.61 | |
| Lyell Immunopharma (LYEL) | 23.3 | $87M | 13M | 6.52 | |
| Pharvaris N V (PHVS) | 19.3 | $72M | 3.2M | 22.10 | |
| Aclaris Therapeutics (ACRS) | 10.6 | $39M | 2.8M | 13.96 | |
| Kura Oncology (KURA) | 9.1 | $34M | 1.8M | 18.33 | |
| Nurix Therapeutics (NRIX) | 2.3 | $8.6M | 677k | 12.67 | |
| Cymabay Therapeutics | 1.4 | $5.3M | 1.8M | 2.95 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 1.1 | $4.1M | 1.8M | 2.32 |
